about
Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategiesTargeting mast cells in gastric cancer with special reference to bone metastasesTargeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategyDevelopment of resistance towards artesunate in MDA-MB-231 human breast cancer cellsCyclophilin B expression is associated with in vitro radioresistance and clinical outcome after radiotherapy.Nix protein positively regulates NF-κB activation in gliomasTissue transglutaminase constitutively activates HIF-1α promoter and nuclear factor-κB via a non-canonical pathway.Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathwaysCuraxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer.Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancerThe C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1.Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cellsEnhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway.Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signalsChemical genetics: exploring the role of the proteasome in cell biology using natural products and other small molecule proteasome inhibitors.Regression of drug-resistant lung cancer by the combination of rosiglitazone and carboplatin.RETRACTED: 3,3'-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer.Dual blockade of PKA and NF-κB inhibits H2 relaxin-mediated castrate-resistant growth of prostate cancer sublines and induces apoptosis.Tumor-derived p53 mutants induce NF-kappaB2 gene expression.Escin Chemosensitizes Human Pancreatic Cancer Cells and Inhibits the Nuclear Factor-kappaB Signaling Pathway.
P2860
Q24645225-B0121BF3-4348-44C4-86EB-E92AC297CEBFQ26784456-BA2EC15B-B747-48F1-81FF-22586F7D3B87Q26863340-1D65BCC7-85CC-4FFA-B557-27C86BF96EB8Q28478307-22479F75-2DD8-4CEA-9B0E-4EBA8B4DEB8FQ30428813-08A28509-591A-4414-B75A-A9F5BC8582A0Q34415970-7125973F-D059-4AFD-B574-C64CA69A7248Q34489967-95137DD2-9645-4EF4-99EA-98C01FA9B936Q34603280-310E2A6C-E33C-4D1E-A8E3-A5AF78456817Q34957154-052F99A7-855A-497B-8696-7930097E22D2Q34979334-8255D5DE-EF5F-4FD2-90B3-2FF360234235Q35194201-A76DF20F-EA42-49E6-AB94-3F4928E10B96Q35486194-33D32192-A597-482A-B8FD-712435EBDCA1Q35578720-66339588-544B-4C19-BEF0-3AB91E004E66Q36907152-CA66F008-E2E6-4EBB-9877-540299A07EFCQ36915734-26288A3A-2DBF-4C09-A28F-BEFE1A1666D5Q37226800-30A6EBC9-B990-4FCF-8915-55FD38C0C31EQ37345627-B61520A1-F22D-41AC-A4C3-4AB71905A976Q38501336-E6B85AC3-7DD6-4E5E-9295-200B4A19607BQ39614332-25053CB9-4926-444F-9734-6A7150BD46E0Q41815302-5360C740-2D1D-4D43-AE7E-86A102FB524E
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
NFkappaB-dependent chemoresistance in solid tumors.
@ast
NFkappaB-dependent chemoresistance in solid tumors.
@en
type
label
NFkappaB-dependent chemoresistance in solid tumors.
@ast
NFkappaB-dependent chemoresistance in solid tumors.
@en
prefLabel
NFkappaB-dependent chemoresistance in solid tumors.
@ast
NFkappaB-dependent chemoresistance in solid tumors.
@en
P356
P1476
NFkappaB-dependent chemoresistance in solid tumors
@en
P2093
P304
P356
10.5414/CPP40336
P577
2002-08-01T00:00:00Z